ArticleMethods in molecular biology (Clifton, N.J.)2025
Mucins as Inhibitors Against Bacterial Adhesion to Epithelial Cells.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The mucus layer protects the epithelium and is a barrier against pathogens. Mucins, a component of the mucus, protect the epithelial surfaces from pathogens by binding and removing them. Different cell lines have been used to study the adhesion of bacteria to epithelial cells and the downstream effects of interactions between pathogens and epithelia. Here, we present a method to evaluate the ability of mucins to inhibit the binding of bacteria to epithelial cells. For this example, we used gastric mucins from a noninfected human, the bacteria Helicobacter pylori strain P12, and the gastric adenocarcinoma cell line MKN7. However, the method also works with mucins from other sources and other bacteria and cell lines. Considerations for choosing appropriate cell lines and how to adapt the protocol for fast-growing bacteria are also discussed.
Indexed as
Identifiers
40498305What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.